P01 CA116676/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2007	4
2008	8
2009	11
2010	10
2011	11
2012	15
2013	19
2014	12
2015	13
2016	3
2017	4
2018	1
2021	2
2024	0

1

Dysregulation of mTOR activity through LKB1 inactivation.

Zhou W, Marcus AI, Vertino PM. Zhou W, et al. Chin J Cancer. 2013 Aug;32(8):427-33. doi: 10.5732/cjc.013.10086. Epub 2013 May 14. Chin J Cancer. 2013. PMID: 23668926 Free PMC article. Review.

2

Targeting protein-protein interactions as an anticancer strategy.

Ivanov AA, Khuri FR, Fu H. Ivanov AA, et al. Trends Pharmacol Sci. 2013 Jul;34(7):393-400. doi: 10.1016/j.tips.2013.04.007. Epub 2013 May 29. Trends Pharmacol Sci. 2013. PMID: 23725674 Free PMC article. Review.

3

mTOR kinase inhibitors as potential cancer therapeutic drugs.

Sun SY. Sun SY. Cancer Lett. 2013 Oct 28;340(1):1-8. doi: 10.1016/j.canlet.2013.06.017. Epub 2013 Jun 20. Cancer Lett. 2013. PMID: 23792225 Free PMC article. Review.

4

Altered glutamine metabolism and therapeutic opportunities for lung cancer.

Mohamed A, Deng X, Khuri FR, Owonikoko TK. Mohamed A, et al. Clin Lung Cancer. 2014 Jan;15(1):7-15. doi: 10.1016/j.cllc.2013.09.001. Epub 2013 Nov 13. Clin Lung Cancer. 2014. PMID: 24377741 Free PMC article. Review.

5

TIF-IA: An oncogenic target of pre-ribosomal RNA synthesis.

Jin R, Zhou W. Jin R, et al. Biochim Biophys Acta. 2016 Dec;1866(2):189-196. doi: 10.1016/j.bbcan.2016.09.003. Epub 2016 Sep 15. Biochim Biophys Acta. 2016. PMID: 27641688 Free PMC article. Review.

6

Impact of genetic alterations on mTOR-targeted cancer therapy.

Sun SY. Sun SY. Chin J Cancer. 2013 May;32(5):270-4. doi: 10.5732/cjc.013.10005. Epub 2013 Mar 15. Chin J Cancer. 2013. PMID: 23489586 Free PMC article. Review.

7

14-3-3 proteins as potential therapeutic targets.

Zhao J, Meyerkord CL, Du Y, Khuri FR, Fu H. Zhao J, et al. Semin Cell Dev Biol. 2011 Sep;22(7):705-12. doi: 10.1016/j.semcdb.2011.09.012. Epub 2011 Oct 1. Semin Cell Dev Biol. 2011. PMID: 21983031 Free PMC article. Review.

8

LKB1 regulated pathways in lung cancer invasion and metastasis.

Marcus AI, Zhou W. Marcus AI, et al. J Thorac Oncol. 2010 Dec;5(12):1883-6. doi: 10.1097/JTO.0b013e3181fbc28a. J Thorac Oncol. 2010. PMID: 21102257 Free PMC article. Review.

9

Enhancing mTOR-targeted cancer therapy.

Wang X, Sun SY. Wang X, et al. Expert Opin Ther Targets. 2009 Oct;13(10):1193-203. doi: 10.1517/14728220903225008. Expert Opin Ther Targets. 2009. PMID: 19694499 Free PMC article. Review.

10

Study on Inhibitory Effect of MaiMenDong Decoction and WeiJing Decoction Combination with Cisplatin on NCI-A549 Xenograft in Nude Mice and Its Mechanism.

Xiong F, Jiang M, Chen M, Wang X, Zhang S, Zhou J, Li K, Sheng Y, Yin L, Tang Y, Ye L, Wu M, Fu H, Zhang X. Xiong F, et al. J Cancer. 2017 Jul 23;8(13):2449-2455. doi: 10.7150/jca.17720. eCollection 2017. J Cancer. 2017. PMID: 28900482 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

103 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Results by year